Skip to main content
Figure 3 | BMC Nephrology

Figure 3

From: The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data

Figure 3

Estimated proportion of patients surviving by levels of IV iron administration. Survival was best in those receiving a low dose of IV iron (L = 1–202 mg per month), and slightly worse in those receiving a moderate dose (M = 202–455 mg per month). Survival was much worse in those who received a high dose (H = > 455 mg per month) and in those who did not receive IV iron (∅ = NO IV).

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us